N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Effect of Menstrual Phase on the Anesthetic Efficacy

Sponsor: Jamia Millia Islamia • ClinicalTrials.gov ID: NCT07306533

Registry updated: 2026-10-08
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The goal of this observational prospective clinical study is to learn whether the menstrual phase influences the anesthetic efficacy of inferior alveolar nerve block (IANB) in female patients aged 20-40 years with symptomatic irreversible pulpitis in mandibular molars. The main questions it aims to answer are: Does the success rate of IANB vary across different phases of the menstrual cycle? Are certain menstrual phases associated with a higher likelihood of anesthetic failure during endodontic access preparation? Researchers will compare five menstrual phase groups (menstrual, follicular, ovulatory, luteal, and premenstrual) to see if hormonal fluctuations affect anesthetic success. Participants will: Receive a standardized inferior alveolar nerve block using 2% lidocaine with 1:80,000 epinephrine Undergo cold testing and access cavity preparation to assess anesthetic success Have intraoperative pain recorded using the Heft-Parker Visual Analog Scale (HPVAS), with menstrual phase information recorded confidentially and blinded to the treating clinician

Interventions

  • Inferior Alveolar Nerve Block (Procedure)
    The patients will receive a standard inferior alveolar nerve block using 1.5 mL of 2% lidocaine with 1:80,000 epinephrine. The efficacy of anesthesia will be evaluated by two measures. First, pulpal anesthesia will be assessed using a cold test with Endo-Ice. Second, intraoperative pain will be recorded during access cavity preparation using the Heft-Parker Visual Analog Scale (HPVAS). Anesthetic outcome will be classified as either success or failure. Success will be defined as absence of response to cold testing along with no or only mild intraoperative pain (HPVAS ≤ 54 mm).

Eligibility criteria

Inclusion Criteria * Female patients aged 20-40 years. * Regular menstrual cycles (28 ± 3 days). * Diagnosed with symptomatic irreversible pulpitis in mandibular molars. * Indicated for root canal therapy. * Willing to provide informed consent. Exclusion Criteria * Use of oral contraceptives or hormonal therapy. * Irregular menstrual cycles. * Pregnancy or lactation. * Systemic disease affecting pain perception (e.g., diabetes, neuropathies). * Recent use of analgesics or sedatives (within 24 hours). * Allergy to local anesthetics.

Conditions

Pulpitis - Irreversible

Locations

  • Faculty of Dentistry, JMI — New Delhi, Delhi(दिल्ली), India
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record